Issued Patents All Time
Showing 26–50 of 62 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 7348315 | Methods of treating heart failure with modified ATP, ADP and AMP compounds | Bruce Liang | 2008-03-25 |
| 7199127 | Purine nucleosides | Lak Shin Jeong, Hyung Ryong Moon, Hea Ok Kim | 2007-04-03 |
| 7087589 | Methanocarba cycloakyl nucleoside analogues | Victor E. Marquez | 2006-08-08 |
| 6586413 | Methods and compositions for reducing ischemic injury of the heart by administering adenosine receptor agonists and antagonists | Bruce Liang | 2003-07-01 |
| 6545002 | Substituted 8-phenylxanthines useful as antagonists of A2B adenosine receptors | Joel M. Linden, Yong Chul Kim | 2003-04-08 |
| 6528516 | Methods for reducing intraocular pressure using A3 adenosine receptor antagonists | Mortimer M. Civan, Richard A. Stone, Claire Mitchell | 2003-03-04 |
| 6376521 | A3 adenosine receptor antagonists | An-Hu Li | 2002-04-23 |
| 6329349 | Methods for reducing ischemic injury of the heart via the sequential administration of monophosphoryl lipid A and adenosine receptor agents | Bruce Liang | 2001-12-11 |
| 6316423 | Method of treating ischemic, hypoxic and anoxic brain damage | Dag K. J. E. Von Lubitz | 2001-11-13 |
| 6211165 | Methods and compositions for reducing ischemic injury of the heart by administering adenosine receptor agonists and antagonists | Bruce Liang | 2001-04-03 |
| 6083954 | Method of treating cystic fibrosis | Harvey B. Pollard | 2000-07-04 |
| 6066642 | Dihydropyridine-, pyridine-, benzopyran-4-one- and triazoloquinazoline derivative, their preparation and their use as adenosine receptor antagonists | Ji Jiang, Yong Chul Kim, Yishai Karton, Albert van Rhee | 2000-05-23 |
| 5877179 | Xanthines for identifying CFTR--binding compounds useful for activating chloride conductance in animal cells | Harvey B. Pollard | 1999-03-02 |
| 5861405 | S-substituted 1,3,7-trialkyl-xanthine derivatives | Yishai Karton, Carola Gallo-Rodriguez, Bilha Fischer, Philip J. M. van Galen, Michel Maillard | 1999-01-19 |
| 5859019 | Methods for protecting against cardiac ischemia by administering adenosine A.sub.2a receptor antagonists | Bruce Liang | 1999-01-12 |
| 5773423 | A3 adenosine receptor agonists | Carola Gallo-Rodriguez, Philip J. M. van Galen, Dag K. J. E. Von Lubitz, Heaok Kim Jeong | 1998-06-30 |
| 5688774 | A.sub.3 adenosine receptor agonists | Heaok Kim Jeong, Suhaib Siddiqi, Carl R. Johnson, John A. Secrist, III, Kamal N. Tiwari | 1997-11-18 |
| 5620676 | Biologically active ATP analogs | Bilha Fischer, Michel Maillard | 1997-04-15 |
| 5545627 | Irreversible inhibitors of adenosine receptors | Gary Stiles | 1996-08-13 |
| 5498605 | Sulfo-derivatives of adenosine | Michel Maillard | 1996-03-12 |
| 5453426 | Sulfur-containing xanthine derivatives as adenosine antagonists | Wolfgang Pfleidover, John W. Daly, John L. Neumeyer | 1995-09-26 |
| 5366977 | Method of treating cystic fibrosis using 8-cyclopentyl-1,3-dipropylxanthine or xanthine amino congeners | Harvey B. Pollard, Philip J. M. van Galen | 1994-11-22 |
| 5324832 | Muscarinic antagonists | Barton James Bradbury, Yishai Karton | 1994-06-28 |
| 5310916 | Trifunctional agents useful as irreversible inhibitors of A1-adenosine receptors | Gary Stiles, Daniel L. Boring | 1994-05-10 |
| 5298508 | Irreversible inhibitors of adenosine receptors | Gary Stiles | 1994-03-29 |